These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 3490716

  • 1. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN, Galstian AM, Ovanesbekova TG, Ter-Pogosian ZR, Kuznetsov VP.
    Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Morphological and immunologic changes following intratumoral administration of alpha interferon in patients with breast cancer].
    Polevaia EB, Ermilova VD, Kupin VI.
    Vopr Onkol; 1986; 32(12):19-23. PubMed ID: 3492075
    [Abstract] [Full Text] [Related]

  • 4. [Immunomodulating effect of interferon after its intra-tumor administration in patients with breast cancer].
    Polevaia EB, Kupin VI, Ermilova VD, Kuznetsov VP, Frolova IS.
    Sov Med; 1988; (2):23-6. PubMed ID: 3260405
    [No Abstract] [Full Text] [Related]

  • 5. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
    Kupin VI, Polevaia EB.
    Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunologic reactivity in patients with breast carcinoma treated with interferon alpha].
    Stanojević-Bakić N, Vucković-Dekić Lj, Inić M, Tomin R.
    Glas Srp Akad Nauka Med; 1994; (44):71-82. PubMed ID: 7590417
    [Abstract] [Full Text] [Related]

  • 8. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D, Fritze J, Kaufmann M, Drings P.
    Minerva Med; 1978 Nov 30; 69(58):3963-7. PubMed ID: 740287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD, Polevaia EB, Derevnina NA, Sablikova IuA, Savinov AIu.
    Eksp Onkol; 1985 Nov 30; 7(6):69-73. PubMed ID: 3910405
    [Abstract] [Full Text] [Related]

  • 11. [Cellular immunity in breast cancer patients].
    Spielmann M, Kitschke HJ, Tietje K.
    Onkologie; 1982 Aug 30; 5 Suppl():42-5. PubMed ID: 6752790
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH, Holland JF, Bekesi JG.
    J Clin Lab Immunol; 1982 Dec 30; 9(3):151-7. PubMed ID: 6762442
    [Abstract] [Full Text] [Related]

  • 14. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G, Thomson DM, MacFarlane JK.
    Cancer Res; 1984 Mar 30; 44(3):1238-45. PubMed ID: 6420056
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C, Kayser S, Stumm S, Watermann I, Walter S, Stevanoviç S, Wallwiener D, Gückel B.
    Clin Cancer Res; 2003 Oct 01; 9(12):4376-86. PubMed ID: 14555509
    [Abstract] [Full Text] [Related]

  • 19. [Cellular immunity indices in benign breast tumors].
    Baisheva SA, Zhalgasbaeva GT, Kaliev IuSh, Mezinova NN.
    Vopr Onkol; 1980 Oct 01; 26(5):15-9. PubMed ID: 7385708
    [Abstract] [Full Text] [Related]

  • 20. [Effect of immunomodifier on radiation-induced antitumor immunity following local irradiation to tumor--2. Mouse interferon-alpha/beta].
    Mukae S, Norimura T, Tsuchiya T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct 25; 48(10):1243-8. PubMed ID: 3222138
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.